Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538639 · ClinicalTrials.gov registry record
Vascular Disease Discovery Protocol
A clinical trial of Genetic Predisposition and Genetic Mutations, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03538639: Recruiting study of Genetic Predisposition and Genetic Mutations, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT03538639 is a study of Genetic Predisposition and Genetic Mutations that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 1,000 participants, below the 3,449-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03538639, a study of Genetic Predisposition and Genetic Mutations, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Some genetic diseases put increase the risk of heart and blood diseases, which are the number one cause of death and disability in the U.S. Researchers want to study diseases of the heart and/or blood vessels. They want to collect data and specimens from affected people, their family members, and healthy people. Objective: To study diseases of the heart and/or blood vessels. Eligibility: People age 2 and older who may have genetic disease affecting the heart and/or blood vessels Their relatives Healthy volunteers Design: Participants will be screened with a medical history, physical exams, and imaging tests. Participants may have a few visits or visits for 2 weeks or more. This will depend on their age and disease status. Visits may include: Photographs of the face and body Heart tests Samples taken of blood, urine, saliva, skin, and/or tissue Scans. For some, a dye may be injected into a vein. A six-minute walk test Lung tests. For some, participants will blow into a tube. For others, they will breathe in a gas from a mask, have a small injection, then have a scan. Stress tests while walking on a treadmill or riding a stationary bike Ultrasound of veins and arteries Devices outside the body testing the stiffness and function of arteries Eye exam and eye tests. For some, a dye may be injected in a vein. Blood pressure tests Measurements of blood flow under the skin and in the arms and fingernail blood vessels Devices outside the body testing flexibility of the blood vessels and skin, and skin temperature
Primary Outcome
Understanding of disease pathophysiology in subjects with uncommon vascular disease presentation.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2037-05-15 |
What NCT03538639 shows while recruiting
NCT03538639 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,449-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (71% lower).
The record links to 3 conditions, with Genetic Predisposition appearing as the primary indexed condition, and to 0 interventions.
NCT03538639 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03538639 about?
NCT03538639 is a clinical study titled "Vascular Disease Discovery Protocol". Background: Some genetic diseases put increase the risk of heart and blood diseases, which are the number one cause of death and disability in the U.S. Researchers want to study diseases of the heart and/or blood vessels. They want to collect data and specimens from affected people, their family me...
What is the current status of trial NCT03538639?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2018-07-30. Estimated completion is 2037-05-15.
What conditions does trial NCT03538639 study?
This clinical trial studies the following conditions: Genetic Predisposition, Genetic Mutations, Vascular Dysfunction.
Who is sponsoring clinical trial NCT03538639?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03538639 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Predisposition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03538639's enrollment target sits among peer trials
1,000 4th of 14 higher than 10 of 14 other Genetic Predisposition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Predisposition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
-
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
RECRUITING · Phase 4
-
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
RECRUITING
-
Pancreatic Cancer Early Detection Consortium
RECRUITING
-
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
RECRUITING · Phase 1
-
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI